|
| 23437320 | A small molecule (pluripotin) as a tool for studying cancer stem cell biology: proof of concept. | PLoS One | 2013 |
| 22766217 | Discovery and preliminary SAR of bisbenzylisoquinoline alkaloids as inducers of C/EBPα. | Bioorg Med Chem | 2012 |
| 22460269 | Impact of mutant β-catenin on ABCB1 expression and therapy response in colon cancer cells. | Br J Cancer | 2012 |
| 22870217 | Identification of CBX3 and ABCA5 as putative biomarkers for tumor stem cells in osteosarcoma. | PLoS One | 2012 |
| 21685359 | Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer. | J Natl Cancer Inst | 2011 |
| 21795396 | S100A4-induced cell motility and metastasis is restricted by the Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells. | Mol Biol Cell | 2011 |
| 21749055 | Cysteine 81 is critical for the interaction of S100A4 and myosin-IIA. | Biochemistry | 2011 |
| 21794960 | Imidazo[2,1-b]thiazole guanylhydrazones as RSK2 inhibitors. | Eur J Med Chem | 2011 |
| 21593990 | RSK2 Binding Models Delineate Key Features for Activity. | J Chem Pharm Res | 2010 |
| 20178109 | Complex display of putative tumor stem cell markers in the NCI60 tumor cell line panel. | Stem Cells | 2010 |
| 20176111 | 12 Arylstibonic acids that inhibit the DNA binding of five B-ZIP dimers. | J Struct Biol | 2010 |
| 20362353 | The arylstibonic acid compound NSC13746 disrupts B-ZIP binding to DNA in living cells. | Eur J Cell Biol | 2010 |
| 19405508 | Cytotoxic and HIF-1alpha inhibitory compounds from Crossosoma bigelovii. | J Nat Prod | 2009 |
| 19093800 | Inhibitors of the NF-kappaB activation pathway from Cryptocarya rugulosa. | J Nat Prod | 2009 |
| 18199535 | Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen. | Cancer Res | 2008 |
| 18302092 | Separation and SAR study of HIF-1alpha inhibitory tubulosines from Alangium cf. longiflorum. | Planta Med | 2008 |
| 17616632 | Identification of a Bis-guanylhydrazone [4,4'-Diacetyldiphenylurea-bis(guanylhydrazone); NSC 109555] as a novel chemotype for inhibition of Chk2 kinase. | Mol Pharmacol | 2007 |
| 17330085 | Development of recombinant adeno-associated virus vectors carrying small interfering RNA (shHec1)-mediated depletion of kinetochore Hec1 protein in tumor cells. | Gene Ther | 2007 |
| 17272646 | Detailed DNA methylation profiles of the E-cadherin promoter in the NCI-60 cancer cells. | Mol Cancer Ther | 2007 |
| 17315309 | Identification of a new natural camptothecin analogue in targeted screening for HIF-1alpha inhibitors. | Planta Med | 2007 |
| 17339364 | Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study. | Mol Cancer Ther | 2007 |
| 16648555 | Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel. | Mol Cancer Ther | 2006 |
| 16397212 | Ligand-directed surface profiling of human cancer cells with combinatorial peptide libraries. | Cancer Res | 2006 |
| 16723234 | Homology model of RSK2 N-terminal kinase domain, structure-based identification of novel RSK2 inhibitors, and preliminary common pharmacophore. | Bioorg Med Chem | 2006 |
| 15840499 | A high-throughput fluorescence-anisotropy screen that identifies small molecule inhibitors of the DNA binding of B-ZIP transcription factors. | Anal Biochem | 2005 |
| 16103101 | Substituted purine analogues define a novel structural class of catalytic topoisomerase II inhibitors. | Cancer Res | 2005 |
| 14749124 | Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity. | Cancer Cell | 2004 |
| 15501957 | Components of the cell death machine and drug sensitivity of the National Cancer Institute Cell Line Panel. | Clin Cancer Res | 2004 |
| 14500354 | Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic, and tissue array profiling. | Cancer Res | 2003 |
| 12927820 | A high-throughput screen for identification of molecular mimics of Smac/DIABLO utilizing a fluorescence polarization assay. | Anal Biochem | 2003 |
| 14695175 | Karyotypic complexity of the NCI-60 drug-screening panel. | Cancer Res | 2003 |
| 14502277 | Identification of PDGFR as a receptor for AAV-5 transduction. | Nat Med | 2003 |
| 11944818 | Application of high-throughput, molecular-targeted screening to anticancer drug discovery. | Curr Top Med Chem | 2002 |
| 12045463 | DNA repair protein levels vis-Ã -vis anticancer drug resistance in the human tumor cell lines of the National Cancer Institute drug screening program. | Anticancer Drugs | 2002 |
| 12451985 | Nucleotide excision repair protein levels vis-Ã -vis anticancer drug resistance in 60 human tumor cell lines. | Ai Zheng | 2002 |
| 12154035 | Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. | Cancer Res | 2002 |
| 11290551 | Expression and potential role of Fas-associated phosphatase-1 in ovarian cancer. | Am J Pathol | 2001 |
| 11181500 | P450 enzyme expression patterns in the NCI human tumor cell line panel. | Drug Metab Dispos | 2001 |
| 10815900 | Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. | Clin Cancer Res | 2000 |
| 10700175 | A gene expression database for the molecular pharmacology of cancer. | Nat Genet | 2000 |
| 11085534 | An informatics approach identifying markers of chemosensitivity in human cancer cell lines. | Cancer Research | 2000 |
| 9679980 | Expression and location of Hsp70/Hsc-binding anti-apoptotic protein BAG-1 and its variants in normal tissues and tumor cell lines. | Cancer Res | 1998 |
| 9850056 | IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. | Cancer Research | 1998 |
| 9422523 | Expression and location of pro-apoptotic Bcl-2 family protein BAD in normal human tissues and tumor cell lines. | Am J Pathol | 1998 |
| 9625176 | Cell line designation change: multidrug-resistant cell line in the NCI anticancer screen. | J Natl Cancer Inst | 1998 |
| 8994024 | An information-intensive approach to the molecular pharmacology of cancer. | Science | 1997 |
| 9331090 | Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. | Cancer Res | 1997 |
| 9365500 | The NCI anti-cancer drug screen: a smart screen to identify effectors of novel targets. | Anticancer Drug Des | 1997 |
| 9150955 | A protein expression database for the molecular pharmacology of cancer. | Electrophoresis | 1997 |
| 8631022 | An abnormality in the p53 pathway following gamma-irradiation in many wild-type p53 human melanoma lines. | Cancer Res | 1996 |